| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/31/2005 | WO2005028640A1 Method for isolating hepatocytes |
| 03/31/2005 | WO2005028622A2 Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| 03/31/2005 | WO2005028503A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | WO2005028017A1 Device and method for applying active substances to the surface of a wound |
| 03/31/2005 | WO2005027949A1 Turmeric-containing composition |
| 03/31/2005 | WO2005027944A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 03/31/2005 | WO2005027943A1 Method for the production of an agent from larvae in flies for treating wounds and agent produced according to said method |
| 03/31/2005 | WO2005027942A1 Pharmaceutical active ingredient made from snake poison to fight against melanomas |
| 03/31/2005 | WO2005027941A1 Skin preparation for external use |
| 03/31/2005 | WO2005027808A1 Calcium zeolite hemostatic agent |
| 03/31/2005 | WO2005002600A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 03/31/2005 | WO2005001076A3 Postpartum cells derived from placental tissue, and methods of making and using the same |
| 03/31/2005 | WO2004113512A3 Method of generating islet beta-cells from exocrine pancreatic cells |
| 03/31/2005 | WO2004101772A3 Neural cells |
| 03/31/2005 | WO2004058305A3 Encapsulated cell for therapy |
| 03/31/2005 | US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening |
| 03/31/2005 | US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders |
| 03/31/2005 | US20050070493 Methods and compositions for treating Parkinson's disease |
| 03/31/2005 | US20050070474 Methods of treatment and compositions therefor |
| 03/31/2005 | US20050070463 membrane proteins associated with LPSs (lipopolysaccharides), for inducing maturation of dendritic cells; membrane fraction has a proteoglycan titer, represented by the sum of the contents of galactose and of proteins, between 1.2 g/l - 3.4 g/l for galactose and between 7.5 g/l - 14.9 g/l for proteins |
| 03/31/2005 | US20050069989 Isoflavone-beta-D-glucan produced by agaricus blazei in the submerged liquid culture and method of producing same |
| 03/31/2005 | US20050069960 Which induce proliferation of tumor-infiltrating lymphocytes without systemic toxicity associated with the administration of wild-type cytokines; drug screening/design |
| 03/31/2005 | US20050069865 Synthetic hcv envelope proteins and their use for vaccination |
| 03/31/2005 | US20050069569 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 03/31/2005 | US20050069536 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 03/31/2005 | US20050069529 Methods of making pancreatic islet cells |
| 03/31/2005 | US20050069526 Promoting Recovery from Damage to the Central Nervous System |
| 03/31/2005 | US20050069525 Nerve repair unit and method of producing it |
| 03/31/2005 | US20050069505 Orally administrable composition for the photoprotection of the skin |
| 03/31/2005 | US20050069491 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression |
| 03/31/2005 | DE10341518A1 Pharmazeutischer Wirkstoff gegen Hepatitis Pharmaceutical drug for hepatitis |
| 03/31/2005 | DE10341307A1 Pharmarzeutischer Wirkstoff gegen Brustkrebs Pharmarzeutischer agent against breast cancer |
| 03/31/2005 | DE10331202A1 Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms Use of whey permeate for the treatment of metabolic syndrome |
| 03/31/2005 | CA2539789A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | CA2539074A1 Campylobacter polypeptides and methods of use |
| 03/31/2005 | CA2539002A1 Method for isolating hepatocytes |
| 03/31/2005 | CA2538998A1 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 03/31/2005 | CA2538066A1 Device and method for applying active substances to the surface of a wound |
| 03/31/2005 | CA2538065A1 Method for the production of an agent from larvae in flies for treating wounds and agent produced according to said method |
| 03/31/2005 | CA2535208A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 03/30/2005 | EP1517715A2 Decellularized tissue |
| 03/30/2005 | EP1203088B1 Conditionally controlled, attenuated hiv vaccine |
| 03/30/2005 | EP1183361B1 Gene therapy of pulmonary disease |
| 03/30/2005 | EP0863763B1 Use of a dehydrated preparation containing propionic bacteria for the manufacture of a dietary composition for improving the biological balance of intestinal tract flora |
| 03/30/2005 | CN1602353A Isolated phages and their use in food or pet food products |
| 03/30/2005 | CN1602351A Islet cells from human embryonic stem cells |
| 03/30/2005 | CN1602316A Flavivirus NS1 subunit vaccine |
| 03/30/2005 | CN1602203A Use of gp130 activators in diabetic neuropathy |
| 03/30/2005 | CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/30/2005 | CN1602193A Beverage treated with nicotine |
| 03/30/2005 | CN1600323A Short corynebacteria pharmaceutics or short corynebacteria pharmaceutics without cells in application for preparing medicine of curing HIV infection or AIDS |
| 03/30/2005 | CN1600322A Combination of propolis, preparation method and usage |
| 03/30/2005 | CN1600321A Capsule of ass-skin glue and preparation method |
| 03/30/2005 | CN1600320A Instant agent of donkey-hide gelatin and preparation method |
| 03/30/2005 | CN1195062C Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses |
| 03/30/2005 | CN1195055C Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
| 03/30/2005 | CN1194758C Vaginal lactobacillus medicant |
| 03/30/2005 | CN1194755C Medicine for treating hepatitis B and its preparation method |
| 03/30/2005 | CN1194753C Medicine for treating head wind syndrome |
| 03/30/2005 | CN1194751C Bone-strengthening medicine, method for preparing tablet, capsule and oral liquor using same |
| 03/30/2005 | CN1194743C Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof |
| 03/30/2005 | CN1194737C Chinese patent drug for preventing miscarriage and promoting health growth of fetus and process for preparing same |
| 03/30/2005 | CN1194735C Chinese medicine for treating hyperplasia of mammary glands |
| 03/30/2005 | CN1194734C Pill for treating hepatitis B |
| 03/30/2005 | CN1194733C Medicine for treating hyperthyroidism and its prepn |
| 03/30/2005 | CN1194731C Orally taken fracture setting Chinese medicine |
| 03/30/2005 | CN1194728C Pellet capable of curing infantile anorexia and convulsion |
| 03/30/2005 | CN1194727C Acne-treating composition |
| 03/30/2005 | CN1194726C Capsule for treating cervical spondylopathy and its preparing process |
| 03/30/2005 | CN1194725C Apoplexia hemiplegic recovered capsule and preparing method thereof |
| 03/30/2005 | CN1194722C Shugan Zhitong soft extract for treating hepatitis |
| 03/30/2005 | CN1194720C Disinfecting liniment for treating skin disease |
| 03/30/2005 | CN1194718C Plaster for treating pains of neck, shoulder, waist and leg and prepn, process |
| 03/30/2005 | CN1194717C Snake poison capsule for treating lung cancer and its preparation method |
| 03/30/2005 | CN1194712C Powerful pain-stopping aerosol |
| 03/30/2005 | CN1194709C Kidney invigorating and bone strengthening medicine and its preparing method |
| 03/30/2005 | CN1194707C Use of lactobacillus casei in immunostimulatory peptides |
| 03/30/2005 | CN1194706C Medicine composition for treating diabetes |
| 03/30/2005 | CN1194705C Natural toad prepared as Chinese medicine for curing AIDS |
| 03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/29/2005 | US6872808 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 03/29/2005 | US6872565 Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
| 03/29/2005 | US6872397 Administering to the patient a therapeutical amount of botulinum toxin of a selected serotype until patient experiences loss of clinical response to the toxin and then administering another botulinum toxin of a different serotype |
| 03/29/2005 | US6872395 Viruses comprising mutant ion channel protein |
| 03/29/2005 | US6872307 Systems and methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes |
| 03/29/2005 | CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA2137271C Apparatus for obtaining a supernatant of activited thrombocytes, process for said apparatus and supernatant thereof |
| 03/29/2005 | CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/24/2005 | WO2005026343A1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 03/24/2005 | WO2005026320A2 Entrapped stem cells and uses thereof |
| 03/24/2005 | WO2005026315A2 Method for producing insulin from a natural source and insulin |
| 03/24/2005 | WO2005026201A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 03/24/2005 | WO2005026130A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 03/24/2005 | WO2005025584A1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 03/24/2005 | WO2005025335A1 Milk fractions and milk preparations for treating and/or preventing cox-2 mediated diseases |
| 03/24/2005 | WO2005010172A3 Aligned scaffolds for improved myocardial regeneration |
| 03/24/2005 | WO2005009498A3 Decellularized bone marrow extracellular matrix |
| 03/24/2005 | WO2005001080A3 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| 03/24/2005 | WO2004112808A3 Therapeutic use of lipids extracted from mother of pearl |
| 03/24/2005 | WO2004108893A3 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |